Furthermore, a large meta-analysis [24] including 11 studies (1147 CRC patients) also found a statistically significant association between PLK1 over-expression and adverse clinico-pathological characteristics, such as advanced stage and lymph node metastasis, further corroborating our findings. The gene discussed is PLK1; the disease is metastatic malignant neoplasm in the lymph nodes.